UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Antimalarial and Anticancer Activity Evaluation of Bridged Ozonides, Aminoperoxides, and Tetraoxanes Journal article
Coghi, Paolo, Yaremenko, Ivan A., Prommana, Parichat, Wu, Jia Ning, Zhang, Rui Long, Ng, Jerome P.L., Belyakova, Yulia Yu, Law, Betty Yuen Kwan, Radulov, Peter S., Uthaipibull, Chairat, Wong, Vincent Kam Wai, Terent'ev, Alexander O.. Antimalarial and Anticancer Activity Evaluation of Bridged Ozonides, Aminoperoxides, and Tetraoxanes[J]. ChemMedChem, 2022, 17(20).
Authors:  Coghi, Paolo;  Yaremenko, Ivan A.;  Prommana, Parichat;  Wu, Jia Ning;  Zhang, Rui Long; et al.
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:3.6/3.5 | Submit date:2023/01/31
1,2,4-trioxanes  Aminoperoxides  Cancer  Malaria  Reactive Oxygen Species  
Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue Journal article
Ng, Jerome P.L., Han, Yu, Yang, Li Jun, Birkholtz, Lyn Marie, Coertzen, Dina, Wong, Ho Ning, Haynes, Richard K., Coghi, Paolo, Wong, Vincent Kam Wai. Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Ng, Jerome P.L.;  Han, Yu;  Yang, Li Jun;  Birkholtz, Lyn Marie;  Coertzen, Dina; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.4/5.0 | Submit date:2023/01/30
Artemisinin  Artemisone  Cancer  Celastrol  Malaria  Redox Drug  Synergism  
The Changing Global Landscape in the Development of Artemisinin-Based Treatments: A Clinical Trial Perspective Journal article
Kong, Xiang Jun, Liu, Kun Meng, Zuo, Hua Li, Huang, Hsien Da, Hu, Yuan Jia. The Changing Global Landscape in the Development of Artemisinin-Based Treatments: A Clinical Trial Perspective[J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50(3), 733-748.
Authors:  Kong, Xiang Jun;  Liu, Kun Meng;  Zuo, Hua Li;  Huang, Hsien Da;  Hu, Yuan Jia
Favorite | TC[WOS]:5 TC[Scopus]:3  IF:4.8/5.0 | Submit date:2022/05/17
Artemisinin  Artemisinin-based Combination Therapy  Clinical Trial  Malaria  Non-malarial Indication  Review